Anti-lymphocyte globulin therapy in aplastic anaemia--a university hospital experience

Med J Malaysia. 1995 Jun;50(2):158-61.

Abstract

Antilymphocyte globulin (ALG) was given every other day for 5 doses with platelet transfusions immediately following ALG administration in 6 patients with aplastic anaemia. Four patients responded and 3 durable remissions were achieved. One patient relapsed and further treatment with anti-thymocyte globulin and cyclosporin also failed. One patient died of Flavobacterium septicaemia 6 days after completion of ALG. Our data suggests that using an alternate day regimen, a response rate similar to a daily regimen can be obtained.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / therapy*
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Female
  • Hospitals, University
  • Humans
  • Male
  • Platelet Transfusion
  • Treatment Outcome

Substances

  • Antilymphocyte Serum